TYNELPA Trademark

Trademark Overview


On Friday, May 19, 2017, a trademark application was filed for TYNELPA with the United States Patent and Trademark Office. The USPTO has given the TYNELPA trademark a serial number of 87457048. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 25, 2024. This trademark is owned by Glaxo Group Limited. The TYNELPA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; all of the foregoing, excluding pharmaceutical preparations for the treatment of hepatitis
tynelpa

General Information


Serial Number87457048
Word MarkTYNELPA
Filing DateFriday, May 19, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 25, 2024
Registration Number5442124
Registration DateTuesday, April 10, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; all of the foregoing, excluding pharmaceutical preparations for the treatment of hepatitis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 25, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Tuesday, May 23, 2017NEW APPLICATION ENTERED
Thursday, May 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 16, 2017ASSIGNED TO EXAMINER
Monday, August 21, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 20, 2017ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, October 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 24, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, November 20, 2017EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, December 15, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, January 8, 2018ASSIGNED TO PETITION STAFF
Friday, September 1, 2017ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, January 10, 2018CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Sunday, March 4, 2018EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 10, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 10, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 25, 2024CANCELLED SEC. 8 (6-YR)